Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Lanreotide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lanreotide 120mg/0.5ml inj pre-filled syringes
0803043P0AAADAD
|
Lanreotide | Lanreotide | Malignant Disease and Immunosuppression | 371 |
|
Lanreotide 60mg/0.5ml inj pre-filled syringes
0803043P0AAAEAE
|
Lanreotide | Lanreotide | Malignant Disease and Immunosuppression | 214 |
|
Lanreotide 90mg/0.5ml inj pre-filled syringes
0803043P0AAAFAF
|
Lanreotide | Lanreotide | Malignant Disease and Immunosuppression | 158 |
|
Lanreotide 30mg inj vials
0803043P0AAAAAA
|
Lanreotide | Lanreotide | Malignant Disease and Immunosuppression | 10 |
|
Lanreotide 60mg/0.3ml inj pre-filled syringes
0803043P0AAABAB
|
Lanreotide | Lanreotide | Malignant Disease and Immunosuppression | No data available |
|
Lanreotide 90mg/0.3ml inj pre-filled syringes
0803043P0AAACAC
|
Lanreotide | Lanreotide | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.